---
title: "Satellos Bioscience Inc. (MSLE.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/MSLE.US.md"
symbol: "MSLE.US"
name: "Satellos Bioscience Inc."
industry: "生物技术"
---

# Satellos Bioscience Inc. (MSLE.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [atellos.com](https://atellos.com) |

## Company Profile

Satellos Bioscience Inc.是一家生物技术公司，主要在加拿大和澳大利亚开发治疗退行性肌肉疾病的药物。该公司使用其专有平台 MyoReGenX，这是一种自动显微镜系统，能够在体外重现肌肉干细胞环境。它正在开发 SAT-3247，这是一种用于治疗杜氏肌营养不良症的口服小分子药物候选者。该公司与渥太华医院研究所（OHRI）签订了许可协议，并与不列颠哥伦比亚大学签订了选项协议

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -11.81 | 465/606 | - | - | - |
| PB | 7.49 | 355/606 | 6.98 | 6.83 | 6.72 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-25T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 12.35 |
| Highest Target | 40.00 |
| Lowest Target | 40.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/MSLE.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/MSLE.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/MSLE.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.